Structure modeling of the chemokine receptor CCR5: Implications for ligand binding and selectivity

被引:71
|
作者
Paterlini, MG
机构
[1] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S0006-3495(02)75307-1
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The G-protein coupled receptor CCR5 is the main co-receptor for macrophage-tropic HIV-1 strains. I have built a structural model of the chemokine receptor CCR5 and used it to explain the binding and selectivity of the antagonist TAK779. Models of the extracellular (EC) domains of CCR5 have been constructed and used to rationalize current biological data on the binding of HIV-1 and chemokines. Residues spanning the transmembrane region of CCR5 have been modeled after rhodopsin, and their functional significance examined using the evolutionary trace method. The receptor cavity shares six residues with CC-chemokine receptors CCR1 through CCR4, while seven residues are unique to CCR5. The contribution of these residues to ligand binding and selectivity is tested by molecular docking simulations of TAK779 to CCR1, CCR2, and CCR5. TAK779 binds to CCR5 in the cavity formed by helices 1, 2, 3, and 7 with additional interactions with helices 5 and 6. TAK779 did not dock to either CCR1 or CCR2. The results are consistent with current site-directed mutagenesis data and with the observed selectivity of TAK779 for CCR5 over CCR1 and CCR2. The specific residues responsible for the observed selectivity are identified. The four EC regions of CCR5 have been modeled using constrained simulated annealing simulations. Applied dihedral angle constraints are representative of the secondary structure propensities of these regions. Tertiary interactions, in the form of distance constraints, are generated from available epitope mapping data. Analysis of the 250 simulated structures provides new insights to the design of experiments aimed at determining residue-residue contacts across the EC domains and for mapping CC-chemokines on the surface of the EC domains.
引用
收藏
页码:3012 / 3031
页数:20
相关论文
共 50 条
  • [41] Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor
    de Groot, Marjan
    Teunissen, Marcel B. M.
    Ortonne, Jean P.
    Lambert, Julien R.
    Naeyaert, Jean M.
    Picavet, Daisy I.
    Arreaza, M. Gladys
    Simon, Jason S.
    Kraan, Maarten
    Bos, Jan D.
    de Rie, Menno A.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 299 (07) : 305 - 313
  • [42] CCR5 chemokine receptor gene polymorphisms in ocular toxoplasmosis
    de Faria Junior, Geraldo M.
    Ayo, Christiane M.
    de Oliveira, Amanda P.
    Lopes, Alessandro G.
    Frederico, Fabio B.
    Silveira-Carvalho, Aparecida P.
    Previato, Mariana
    Barbosa, Amanda P.
    Murata, Fernando H. A.
    de Almeida Junior, Gildasio Castello
    Siqueira, Rubens Camargo
    de Mattos, Luiz C.
    Brandao de Mattos, Cinara C.
    ACTA TROPICA, 2018, 178 : 276 - 280
  • [43] Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy
    Calzada, JE
    Nieto, A
    Beraún, Y
    Martín, J
    TISSUE ANTIGENS, 2001, 58 (03): : 154 - 158
  • [44] Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5
    Yuan, Yunyun
    Arnatt, Christopher K.
    Li, Guo
    Haney, Kendra M.
    Ding, Derong
    Jacob, Joanna C.
    Selley, Dana E.
    Zhang, Yan
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (13) : 2633 - 2646
  • [45] Classical QSAR modeling of CCR5 receptor binding affinity of substituted benzylpyrazoles
    Leonard, JT
    Roy, K
    QSAR & COMBINATORIAL SCIENCE, 2004, 23 (06): : 387 - 398
  • [46] Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (Delta 32 CCR5)
    McNicholl, JM
    Smith, DK
    Qari, SH
    Hodge, T
    EMERGING INFECTIOUS DISEASES, 1997, 3 (03) : 261 - 271
  • [47] CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis
    Petrek, M
    Gibejova, A
    Drabek, J
    Mrazek, F
    Kolek, V
    Weigl, E
    du Bois, RM
    IMMUNOLOGY LETTERS, 2002, 80 (03) : 189 - 193
  • [48] The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection
    Abdi, R
    Smith, RN
    Makhlouf, L
    Najafian, N
    Luster, AD
    Auchincloss, H
    Sayegh, MH
    DIABETES, 2002, 51 (08) : 2489 - 2495
  • [49] Incorporation of Fluorescently Tagged Chemokine Receptor 5 (CCR5) into Membrane Nanoparticles
    Rico, Carlos A.
    Knepp, Adam M.
    Peeler, Jennifer C.
    Sakmar, Thomas P.
    Huber, Thomas
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 115A - 115A
  • [50] Primary acute dengue and the deletion in chemokine receptor 5 (CCR5Δ32)
    Brestovac, Brian
    Halicki, Larissa A.
    Harris, Ryan P.
    Sampson, Ian
    Speers, David J.
    Mamotte, Cyril
    Williams, David
    MICROBES AND INFECTION, 2014, 16 (06) : 518 - 521